Terns Pharmaceuticals (TERN) Earnings Call Presentation

Interpreting Early CML Datasets and Highlighting the TERN-701 Opportunity NASDAQ: TERN August 2024 Forward-Looking Statements and Disclaimers This presentation contains forward-looking statements about Terns Pharmaceuticals, Inc. (the "Company," "we," "us," or "our") and its industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this presentation, including but not limited to statements regarding beneficial characteristics and potenti ...